Kindred Biosciences (KIN) Tops Q4 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Kindred Biosciences (KIN) Tops Q4 EPS by 9c

Kindred Biosciences Announces Fourth Quarter and Year-End 2014 Financial Results

March 12, 2015 4:01 PM EDT

SAN FRANCISCO, March 12, 2015 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the quarter ended December 31, 2014.  

Conference Call and Webcast at 4:30 p.m. Eastern / 1:30 p.m. Pacific  

KindredBio today announced its fourth quarter financial results and provided updates on its programs.

Development Updates

KindredBio continues to build and advance its pipeline, including biologics, and now has over 20 programs across multiple product candidates and indications. Some of the key programs are highlighted below.

The pivotal field trial of SentiKind, a KCNQ potassium... More